BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 30454040)

  • 1. The physiology of foamy phagocytes in multiple sclerosis.
    Grajchen E; Hendriks JJA; Bogie JFJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):124. PubMed ID: 30454040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.
    Cignarella F; Filipello F; Bollman B; Cantoni C; Locca A; Mikesell R; Manis M; Ibrahim A; Deng L; Benitez BA; Cruchaga C; Licastro D; Mihindukulasuriya K; Harari O; Buckland M; Holtzman DM; Rosenthal A; Schwabe T; Tassi I; Piccio L
    Acta Neuropathol; 2020 Oct; 140(4):513-534. PubMed ID: 32772264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation.
    Grajchen E; Wouters E; van de Haterd B; Haidar M; Hardonnière K; Dierckx T; Van Broeckhoven J; Erens C; Hendrix S; Kerdine-Römer S; Hendriks JJA; Bogie JFJ
    J Neuroinflammation; 2020 Jul; 17(1):224. PubMed ID: 32718316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia-derived macrophages in early multiple sclerosis plaques.
    Li H; Cuzner ML; Newcombe J
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):207-15. PubMed ID: 8804022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia promote remyelination independent of their role in clearing myelin debris.
    Baaklini CS; Ho MFS; Lange T; Hammond BP; Panda SP; Zirngibl M; Zia S; Himmelsbach K; Rana H; Phillips B; Antoszko D; Ibanga J; Lopez M; Lee KV; Keough MB; Caprariello AV; Kerr BJ; Plemel JR
    Cell Rep; 2023 Dec; 42(12):113574. PubMed ID: 38100356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination.
    Shen K; Reichelt M; Kyauk RV; Ngu H; Shen YA; Foreman O; Modrusan Z; Friedman BA; Sheng M; Yuen TJ
    Cell Rep; 2021 Mar; 34(10):108835. PubMed ID: 33691116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination.
    Bajramović JJ; Plomp AC; Goes Av; Koevoets C; Newcombe J; Cuzner ML; van Noort JM
    J Immunol; 2000 Apr; 164(8):4359-66. PubMed ID: 10754336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active liver X receptor signaling in phagocytes in multiple sclerosis lesions.
    Mailleux J; Vanmierlo T; Bogie JF; Wouters E; Lütjohann D; Hendriks JJ; van Horssen J
    Mult Scler; 2018 Mar; 24(3):279-289. PubMed ID: 28273782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inefficient clearance of myelin debris by microglia impairs remyelinating processes.
    Lampron A; Larochelle A; Laflamme N; Préfontaine P; Plante MM; Sánchez MG; Yong VW; Stys PK; Tremblay MÈ; Rivest S
    J Exp Med; 2015 Apr; 212(4):481-95. PubMed ID: 25779633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.
    Kucharova K; Chang Y; Boor A; Yong VW; Stallcup WB
    J Neuroinflammation; 2011 Nov; 8():158. PubMed ID: 22078261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.
    Sen MK; Mahns DA; Coorssen JR; Shortland PJ
    Glia; 2022 Jul; 70(7):1215-1250. PubMed ID: 35107839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair.
    Doring A; Yong VW
    Front Biosci (Schol Ed); 2011 Jun; 3(3):846-56. PubMed ID: 21622236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perilipin-2 limits remyelination by preventing lipid droplet degradation.
    Loix M; Wouters E; Vanherle S; Dehairs J; McManaman JL; Kemps H; Swinnen JV; Haidar M; Bogie JFJ; Hendriks JJA
    Cell Mol Life Sci; 2022 Sep; 79(10):515. PubMed ID: 36100764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
    Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A
    Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a microglia phenotype supportive of remyelination.
    Olah M; Amor S; Brouwer N; Vinet J; Eggen B; Biber K; Boddeke HW
    Glia; 2012 Feb; 60(2):306-21. PubMed ID: 22072381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia.
    Hendrickx DA; Schuurman KG; van Draanen M; Hamann J; Huitinga I
    J Neuroinflammation; 2014 Mar; 11():64. PubMed ID: 24684721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system.
    Rawji KS; Young AMH; Ghosh T; Michaels NJ; Mirzaei R; Kappen J; Kolehmainen KL; Alaeiilkhchi N; Lozinski B; Mishra MK; Pu A; Tang W; Zein S; Kaushik DK; Keough MB; Plemel JR; Calvert F; Knights AJ; Gaffney DJ; Tetzlaff W; Franklin RJM; Yong VW
    Acta Neuropathol; 2020 May; 139(5):893-909. PubMed ID: 32030468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions.
    Laman JD; Visser L; Maassen CB; de Groot CJ; de Jong LA; 't Hart BA; van Meurs M; Schellekens MM
    J Neuroimmunol; 2001 Sep; 119(1):124-30. PubMed ID: 11525809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.